about
Trends in protein-based biosensor assemblies for drug screening and pharmaceutical kinetic studiesCharacterization of oligoadenylate synthetase-1 expression in rat mammary gland and prostate: effects of 17beta-estradiol on the regulation of OAS1g in both tissuesAndrogen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile.Evaluation of the prebiotic potential of arabinoxylans from brewer's spent grain.STEAP proteins: from structure to applications in cancer therapy.Amniotic membrane: from structure and functions to clinical applications.The diverse roles of calcium-binding protein regucalcin in cell biology: from tissue expression and signalling to disease.Pichia pastoris: a recombinant microfactory for antibodies and human membrane proteins.Hormonal regulation of c-KIT receptor and its ligand: implications for human infertility?Targeting STEAP1 protein in human cancer: current trends and future challenges.Oxidative Stress, DNA, Cell Cycle/Cell Cycle Associated Proteins and Multidrug Resistance Proteins: Targets of Human Amniotic Membrane in Hepatocellular Carcinoma.Estrogens down-regulate the stem cell factor (SCF)/c-KIT system in prostate cells: Evidence of antiproliferative and proapoptotic effects.Selective cytotoxicity and cell death induced by human amniotic membrane in hepatocellular carcinoma.5α-Dihydrotestosterone regulates the expression of L-type calcium channels and calcium-binding protein regucalcin in human breast cancer cells with suppression of cell growth.Effect of extracellular calcium on regucalcin expression and cell viability in neoplastic and non-neoplastic human prostate cells.The Emerging Role of Regucalcin as a Tumor Suppressor: Facts and Views.Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer.Endogenous Factors in the Recovery of Reproductive Function After Testicular Injury and Cancer.Liver diseases: what is known so far about the therapy with human amniotic membrane?Effect of amniotic membrane proteins in human cancer cell lines: an exploratory study.Beyond the limits of oxygen: effects of hypoxia in a hormone-independent prostate cancer cell line.Six transmembrane epithelial antigen of the prostate 1 is down-regulated by sex hormones in prostate cells.Regucalcin is under-expressed in human breast and prostate cancers: Effect of sex steroid hormones.STEAP1 is over-expressed in breast cancer and down-regulated by 17beta-estradiol in MCF-7 cells and in the rat mammary gland.Improved minicircle DNA biosynthesis for gene therapy applications.Regucalcin is expressed in rat mammary gland and prostate and down-regulated by 17beta-estradiol.The stem cell factor (SCF)/c-KIT system in carcinogenesis of reproductive tissues: What does the hormonal regulation tell us?Advances in time course extracellular production of human pre-miR-29b from Rhodovulum sulfidophilum.Variability of MMP/TIMP and TGF-β1 Receptors throughout the Clinical Progression of Chronic Venous Disease.Knockdown of STEAP1 inhibits cell growth and induces apoptosis in LNCaP prostate cancer cells counteracting the effect of androgens.The protective effect of regucalcin against radiation-induced damage in testicular cells.Histopathological and in vivo evidence of regucalcin as a protective molecule in mammary gland carcinogenesis.Aging-associated changes in oxidative stress, cell proliferation, and apoptosis are prevented in the prostate of transgenic rats overexpressing regucalcin.Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes.Suppressed glycolytic metabolism in the prostate of transgenic rats overexpressing calcium-binding protein regucalcin underpins reduced cell proliferation.STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.Regucalcin is an androgen-target gene in the rat prostate modulating cell-cycle and apoptotic pathwaysImpact of plasmid induction strategy on overall plasmid DNA yield and E. coli physiology using flow cytometry and real-time PCRAmniotic membrane extract differentially regulates human peripheral blood T cell subsets, monocyte subpopulations and myeloid dendritic cellsGlycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?
P50
Q26859238-EB945875-F36C-4D82-AC31-BB2AFF2896E1Q28578581-90B0BCDE-16F1-4DAA-893E-DCE064EB02BFQ34298773-885976AC-B1A0-4C7D-A61C-1862E44DBE38Q35223730-D4A5A21A-97BF-4999-BCE9-E3D8CC3BD9FBQ38004369-457A746C-36F2-445E-8AB9-14826B15699BQ38010638-EE3CE4BB-CC75-4545-914B-DB96C5934071Q38092029-3B64D4F4-7C97-41AA-915D-AC771929BD2DQ38104572-3C97E260-8A6C-4242-B8F8-BE3FFCC286E7Q38275897-C2F9B867-F2A5-4A2E-9AEE-22B1D5953FD1Q38688906-2143EE3B-C379-485A-BB78-2C0523F92D69Q38787238-2E1B8D28-A303-4929-AC54-4D9D7D289BAFQ38817826-44B27B1C-82D8-451D-8B48-0228EE48EB12Q38824357-97735275-7411-4460-AFA7-6927EF94CEA4Q38845216-FEC90AE8-69F5-4057-A217-FDF5E9234BD1Q38853286-59AAFA74-2FD6-47A8-BB47-1A076C0A5D38Q38895553-CDDF2A9B-B23C-43FD-AC21-F6B182FED392Q38897955-49AED03E-30A1-436B-8A01-7691ECAB6F7EQ38919141-9E1856BB-3C55-435B-BF30-5E90E5E3EC3EQ38934348-ECBFAFC7-743E-431A-9A5C-C0B55CDCCF11Q39020188-13B18097-5C52-4C60-AAC6-F0A0FF3D06F0Q39069174-576CF24B-2BA2-46BE-B3F2-AA245CF0917FQ39260890-7D66D046-A82B-4BEB-8258-0AEDC1491718Q39863880-11E3E7B3-661D-4D05-81C0-C4E8FD74D9A5Q39923922-DE31244F-A7C7-4A4F-8B9E-E489AFEB285AQ44564566-9AABD628-FAE1-4983-88DF-6256284D8D60Q46834454-1A8CB27A-A351-4864-A419-FD86D2CB5464Q47684575-CEF19AAB-C869-4552-B9E8-57A81BDC96E1Q48243256-A9F0BF1A-22F7-4161-965D-B595EEB2466FQ48365214-975076B5-20C7-4F59-B472-2594ECE52BF0Q49722730-5EE0CEBC-8C2E-4E7E-BB7C-0DC6CF207FD3Q51515199-FCA5F6A8-A363-4452-A12E-F11F3CD0A602Q53027185-F3A6093C-05AD-47D5-A28F-A54CADBF1353Q53335819-FB0710EC-E8A5-4AF0-9E71-0BA242849722Q53476667-E75BA744-6B13-4D9C-9F32-78416DEB59E4Q54234970-F5F76C28-547E-4223-966C-E51972E9A41BQ54589955-6A3E8121-3FD3-41B7-BF86-669D06FF371EQ59152983-0F7D4903-9042-434F-8D2E-61960A1F4A88Q59284962-8DBE71B4-E6C2-474D-B695-B6991322291CQ63267768-D5142011-171C-49F0-8503-0A4EC2B825B6Q63267828-1FF94039-9184-46B0-889F-117F4806A7F5
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cláudio Maia
@ast
Cláudio Maia
@en
Cláudio Maia
@es
Cláudio Maia
@nl
Cláudio Maia
@sl
type
label
Cláudio Maia
@ast
Cláudio Maia
@en
Cláudio Maia
@es
Cláudio Maia
@nl
Cláudio Maia
@sl
altLabel
Maia C or Maia CJB
@en
prefLabel
Cláudio Maia
@ast
Cláudio Maia
@en
Cláudio Maia
@es
Cláudio Maia
@nl
Cláudio Maia
@sl
P1053
H-9320-2012
P106
P1153
23097426600
56462347300
P21
P31
P3829
P496
0000-0002-5658-5445
P569
2000-01-01T00:00:00Z